Chang-Hun Ji

Chang-Hun Ji

Auto-generated profile, based on publicly available information

Chang-Hun Ji

Department of Biomedical Science and Engineering

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Metabolic Engineering
Verified
Journal Article
Closed access
CJChang-Hun Ji
Chang-Hun Ji
HKHiyoung Kim
Hiyoung Kim
HJHyun-Woo Je
Hyun-Woo Je
HKHaeun Kwon
Haeun Kwon
DLDongho Lee
Dongho Lee
HKHahk-Soo Kang
Hahk-Soo Kang

23 January 2024 in Natural Product Reports
Verified
Journal Article
Closed access
PDF file
CJChang-Hun Ji
Chang-Hun Ji
HJHyun-Woo Je
Hyun-Woo Je
HKHiyoung Kim
Hiyoung Kim
HKHahk-Soo Kang
Hahk-Soo Kang
Promoter engineering has been used to improve production titers of natural products or to activate transcriptionally silent BGCs. This review summarizes 10 years of progress in promoter engineering approaches in natural products research.

28 October 2024 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
CJChang-Hun Ji
Chang-Hun Ji
SPSehong Park
Sehong Park
KLKunwoo Lee
Kunwoo Lee
HJHyun-Woo Je
Hyun-Woo Je
HKHahk-Soo Kang
Hahk-Soo Kang

2 November 2025 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
CJChang-Hun Ji
Chang-Hun Ji
CKChan-Ik Kim
Chan-Ik Kim
BYBoin Yun
Boin Yun
JKJun-Yong Kim
Jun-Yong Kim
SKSangwook Kang
Sangwook Kang
HKHahk-Soo Kang
Hahk-Soo Kang

9 June 2026 in Materials Today Bio
Verified
Journal Article
Open access
KJKeuna Jeon
Keuna Jeon
UKUijin Kim
Uijin Kim
CJChang-Hun Ji
Chang-Hun Ji
MKMeenakshi Kamaraj
Meenakshi Kamaraj
NLNoah Zachary Laird
Noah Zachary Laird
Natashya FalconeNatashya Falcone
Natashya Falcone
The tumor microenvironment (TME) is a dynamic and heterogeneous ecosystem in which cancer, stromal, immune, and physicochemical components collectively regulate disease progression and therapeutic response. Recent evidence further indicates that intratumoral bacteria are active contributors to tumor metabolism, immune modulation, and treatment outcomes, revealing a previously underexplored multi-kingdom dimension of solid tumors. However, mechanistic understanding of tumor–microbe interactions remain limited by the absence of experimental platforms that integrate microbial components into physiologically relevant and controllable tumor models. Here, we propose bacteria-integrated tumor microenvironments as an emerging bioengineering framework for modeling cancer as a multi-kingdom system with biomaterials. We first lay out the existence of bacteria in our body and outline key design principles for these systems, including control of microbial localization, nutrient and oxygen gradients, and interkingdom signaling within engineered matrices. We further discuss applications in studying microbial contributions to therapeutic resistance, evaluating engineered bacterial therapies, and developing patient-specific tumor–microbiome models for precision oncology. Finally, we highlight challenges in standardizing multi-kingdom tumor platforms and integrating them with advanced imaging, sequencing, and computational tools. Collectively, bacteria-integrated TME establish a new paradigm for engineering cancer as a multi-kingdom system with translational potential in oncology.